About C3D
The Centre for Drug Discovery and Development (C3D) at KL College of Pharmacy is one of its kind, focused on bringing new medicines to life. Here, the faculty involve in bridging the gap between scientific discoveries and usable drugs. This often involves translating promising research from lab into tangible therapies through a multi-step process. They often collaborate with researchers, pharmaceutical companies, and government agencies to develop potential drugs and formulations.
Vision
To be a global leader in pioneering innovative, safe, and effective therapeutics that transform human health and well-being by addressing unmet medical needs through cutting-edge research and technology.
Mission
- To discover and develop novel drugs that improve patient outcomes across a wide range of diseases and disorders.
- To foster collaborative partnerships with academia, industry, and regulatory bodies to accelerate drug discovery and development.
- To advance scientific knowledge and innovation in pharmacology, medicinal chemistry, and biotechnology through interdisciplinary research.
- To train and support the next generation of researchers and professionals in drug discovery and development.
Key Objectives
- To develop and evaluate novel formulations for efficient drug delivery, improved patient compliance, enhanced efficacy and reduced side effects.
- To design small molecules using computational tools, optimize synthetic routes and characterize the synthesized compounds by Mass and NMR spectral methods.
- To conduct preclinical evaluation of novel molecules from both natural and synthetic origins for their pharmacological and toxicological effects
Thrust areas:
- Formulation Development: Development of various formulations including transdermal patches, microneedles array patches of various design features using 3D printing, nanoparticles, and their precise characterization and evaluation
- Medicinal Chemistry: Design and Synthesis of small molecules for potential targets of Cancer, Tuberculosis and Diabetes.
- Preclinical Evaluation: Neuropharmacology, Regulatory toxicology studies.
- Analytical: Method Development and Validation, Impurity profiling.
Outcomes
- Discovery and development of innovative drugs that address unmet medical needs and improve patient outcomes.
- Advancing global knowledge through high-impact publications, patents, and breakthroughs in drug discovery and disease mechanisms.
- Building strong partnerships with industry, academia, and healthcare institutions to accelerate the translation of research into real-world treatments.
For More Information Click Below Link
Center for Drug Discovery and Development
Major Equipments:
UV/Visible Spectrophotometer
UV-1900i, Shimadzu
Stage Franz Diffusion Cell Apparatus,
Orchid Scientific
ATR FT-IR
Alpha II, Bruker
Molecular Devices Spectramax Mini Elisa Plate Reader
Labindia DS 8000 Dissolution Test Apparatus
Spectrlab COD Digestor 2015 D
High Resolution 3D Printer
Sonic 8K mini, Phrozen
Probe Sonicator (with multiple probes)
PCi Analytics
Deep Freezer
Minor Equipments and Facilities:
Bath sonicator
Shimadzu Weighing Balance
Mini Centrifuge (Remi)
Single and Multichannel